Calamos Advisors LLC Grows Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Calamos Advisors LLC raised its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 124.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,725 shares of the company’s stock after buying an additional 13,720 shares during the quarter. Calamos Advisors LLC’s holdings in Guardian Pharmacy Services were worth $501,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. R Squared Ltd purchased a new stake in Guardian Pharmacy Services during the 4th quarter valued at approximately $30,000. Investment Research & Advisory Group Inc. purchased a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at approximately $34,000. Stephens Inc. AR purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $189,000. Virtu Financial LLC purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $279,000. Finally, Barclays PLC purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $311,000.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, Director Steven D. Cosler purchased 7,000 shares of Guardian Pharmacy Services stock in a transaction on Tuesday, November 19th. The shares were bought at an average price of $21.22 per share, with a total value of $148,540.00. Following the completion of the acquisition, the director now directly owns 17,713 shares of the company’s stock, valued at approximately $375,869.86. This trade represents a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Guardian Pharmacy Services Stock Performance

Shares of NYSE GRDN opened at $23.03 on Thursday. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $25.74. The stock’s fifty day moving average is $22.09.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million for the quarter, compared to analysts’ expectations of $303.21 million. Analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on GRDN shares. Stephens started coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price objective on the stock. Truist Financial lifted their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a report on Friday, November 15th. Finally, Raymond James began coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 target price on the stock.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.